Anti-tumour necrosis factor antibody treatment does not change serum levels of cortisol binding globulin in patients with rheumatoid arthritis but it increases androstenedione relative to cortisol

R. H. Straub, P. Sarzi-Puttini, F. Atzeni, F. Buttgereit, M. Carrabba, M. Cutolo

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Anti-tumour necrosis factor antibody treatment does not change serum levels of cortisol binding globulin in patients with rheumatoid arthritis but it increases androstenedione relative to cortisol'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds